# Alpha Fusion

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/alpha-fusion

- Industry: Pharmaceuticals
- Headquarters: Osaka-shi, Japan
- Website: www.alpha-fusion.com
- Total disclosed funding: $10M
- Latest round: Series B (Oct 8, 2024)
- Investors on record: 9

## About

Founded in 2021 and based in Osaka, Japan, Alpha Fusion Inc. operates as a radiopharmaceutical company that offers anticancer drugs. In March 2023, Alpha Fusion Inc. raised JPY 450 million in Series A funding from the Japan Science and Technology Agency, JGC Corporation, Osaka University Venture Capital, and Sumitomo Heavy Industries, Ltd. As of 2023, the company’s CEO is Sunao Fujioka. Alpha Fusion engages in the development and commercialization of astatine-based radiopharmaceuticals for the treatment of cancer. The company offers Astatine-211, which is an alpha-nuclear medicine treatment that targets targeted alpha therapy (TAT) cancer cells for the treatment of cancer. The company plans to use the funds raised in March 2023 to expand the usage of Astatine-211 and develop its radiopharmaceuticals, as well as to promote the unique cancer treatment developed in Japan throughout the world.

## Funding rounds

- Series B, Oct 8, 2024, $6.9M — Global Brain, SBI Investment, Joyo Capital Partners, Osaka University Venture Capital, D3 LLC, Kobe University Capital
- Series A, Mar 7, 2023, $3.3M — Osaka University Venture Capital, Japan Science and Technology Agency, JGC Holdings, Sumitomo Heavy Industries, Ltd., D3 LLC

## Investors

- Osaka University Venture Capital (https://capitalatlas.ai/funds/osaka-university-venture-capital) — Series A, Series B
- Japan Science and Technology Agency — Series A
- JGC Holdings — Series A
- Sumitomo Heavy Industries, Ltd. — Series A
- D3 LLC (https://capitalatlas.ai/funds/d3-llc) — Series A, Series B
- Global Brain (https://capitalatlas.ai/funds/global-brain) — Series B
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series B
- Joyo Capital Partners (https://capitalatlas.ai/funds/joyo-capital-partners) — Series B
- Kobe University Capital (https://capitalatlas.ai/funds/kobe-university-capital) — Series B